GRIMES & Co WEALTH MANAGEMENT LLC lifted its stake in Kimberly-Clark Corporation (NASDAQ:KMB – Free Report) by 7.1% in the third quarter, Holdings Channel.com reports. The fund owned 150,072 shares of the company’s stock after purchasing an additional 10,003 shares during the period. GRIMES & Co WEALTH MANAGEMENT LLC’s holdings in Kimberly-Clark were worth $14,621,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors have also recently made changes to their positions in the company. Mystic Asset Management Inc. grew its position in shares of Kimberly-Clark by 0.5% in the third quarter. Mystic Asset Management Inc. now owns 20,354 shares of the company’s stock valued at $1,983,000 after purchasing an additional 109 shares in the last quarter. Assetmark Inc. lifted its holdings in Kimberly-Clark by 0.6% during the 1st quarter. Assetmark Inc. now owns 20,216 shares of the company’s stock worth $1,950,000 after purchasing an additional 121 shares in the last quarter. Annex Advisory Services LLC boosted its stake in Kimberly-Clark by 2.0% in the 3rd quarter. Annex Advisory Services LLC now owns 6,533 shares of the company’s stock worth $637,000 after purchasing an additional 125 shares during the period. Root Financial Partners LLC boosted its stake in Kimberly-Clark by 17.6% in the 1st quarter. Root Financial Partners LLC now owns 847 shares of the company’s stock worth $82,000 after purchasing an additional 127 shares during the period. Finally, Modera Wealth Management LLC boosted its stake in Kimberly-Clark by 3.9% in the 3rd quarter. Modera Wealth Management LLC now owns 3,414 shares of the company’s stock worth $333,000 after purchasing an additional 129 shares during the period. 76.29% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of research analysts have weighed in on the company. Rothschild & Co Redburn reduced their target price on Kimberly-Clark from $138.00 to $129.00 and set a “buy” rating for the company in a report on Friday, October 9th. BNP Paribas Exane increased their price target on shares of Kimberly-Clark from $101.00 to $110.00 and gave the stock a “neutral” rating in a report on Friday, October 16th. Seaport Research Partners upgraded shares of Kimberly-Clark to a “buy” rating in a research report on Tuesday, August 4th. Bank of America cut their price objective on shares of Kimberly-Clark from $122.00 to $120.00 and set a “buy” rating for the company in a research report on Friday, September 25th. Finally, UBS Group boosted their price objective on shares of Kimberly-Clark from $106.00 to $113.00 and gave the company a “neutral” rating in a research note on Wednesday, October 28th. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, twelve have assigned a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, Kimberly-Clark currently has a consensus rating of “Hold” and a consensus target price of $111.56.
Check Out Our Latest Research Report on Kimberly-Clark
Kimberly-Clark Price Performance
KMB stock opened at $108.25 on Tuesday. The company has a debt-to-equity ratio of 3.45, a current ratio of 0.91 and a quick ratio of 0.69. Kimberly-Clark Corporation has a one year low of $92.42 and a one year high of $116.82. The stock has a market cap of $36.00 billion, a PE ratio of 14.55, a P/E/G ratio of 5.86 and a beta of 0.25. The firm has a 50 day simple moving average of $102.80 and a two-hundred day simple moving average of $103.07.
Kimberly-Clark (NASDAQ:KMB – Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $1.80 earnings per share for the quarter, missing the consensus estimate of $2.01 by ($0.21). The company had revenue of $4.19 billion for the quarter, compared to analysts’ expectations of $4.22 billion. Kimberly-Clark had a net margin of 11.79% and a return on equity of 143.92%. The business’s quarterly revenue was up .6% compared to the same quarter last year. During the same quarter last year, the business posted $1.92 EPS. On average, analysts predict that Kimberly-Clark Corporation will post 6.83 EPS for the current fiscal year.
Key Stories Impacting Kimberly-Clark
Here are the key news stories impacting Kimberly-Clark this week:
- Positive Sentiment: Kenvue acquisition completed: Kimberly-Clark closed the transaction on November 2, adding well-known brands including Tylenol and bringing together 10 billion-dollar brands across complementary consumer-health and personal-care categories. The deal is intended to create a larger, more diversified global consumer-health company. Kimberly-Clark Completes Acquisition of Kenvue
- Positive Sentiment: Large synergy opportunity: Management reiterated anticipated run-rate synergies of approximately $2.1 billion and said it already has a value-capture plan and pipeline. Successful integration and cost savings could support earnings growth and help Kimberly-Clark maintain its long record of dividend increases. Kimberly-Clark Completes Kenvue Acquisition
- Neutral Sentiment: Business transformation: The transaction marks a new chapter for KMB and changes the company’s exposure across consumer staples, healthcare and major stock indexes. The broader portfolio may improve diversification, but investors will be watching how quickly Kenvue contributes to results. Kimberly-Clark Closes Kenvue Acquisition
- Negative Sentiment: Significant financial commitment: The enterprise value of the acquisition is estimated at nearly $49 billion, increasing execution, financing and integration risks. Investors may also expect near-term pressure as Kimberly-Clark absorbs the deal and works to realize promised synergies. Kimberly-Clark Acquires Kenvue
- Negative Sentiment: Q3 concerns: Analysts expect weak consumer spending and rising costs to weigh on the upcoming quarter, although product innovation and efficiency gains could provide partial support. The earnings report will offer an early indication of operating momentum before the acquisition’s benefits are fully reflected. Kimberly-Clark Q3 Earnings Preview
About Kimberly-Clark
Kimberly-Clark Corporation (NASDAQ:KMB) is a global consumer products company that develops and markets personal care, tissue and professional hygiene products. Its portfolio includes products for babies and children, feminine care, adult care, family care and workplace hygiene.
The company’s well-known brands include Huggies diapers and wipes, Kleenex facial tissue, Cottonelle bathroom tissue, Scott toilet paper and paper towels, Kotex feminine care products, and Depend, Poise and GoodNites products.
See Also
- Five stocks we like better than Kimberly-Clark
- AbbVie’s Humira Era Is Fading, But Its New Growth Engines Face Another Test
- GLP-1 Focus or Broader Peptide Exposure: Which ETF Has the Edge?
- Mortgage Rates Froze U.S. Housing, But These 3 Overseas Markets Still Pay Double Digits
- Big Tech Is Spending Billions on AI—These 5 Stocks Are Getting Paid
Want to see what other hedge funds are holding KMB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kimberly-Clark Corporation (NASDAQ:KMB – Free Report).
Receive News & Ratings for Kimberly-Clark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark and related companies with MarketBeat.com's FREE daily email newsletter.
